SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-22-000071
Filing Date
2022-08-11
Accepted
2022-08-11 16:03:55
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20220630.htm   iXBRL 10-Q 958233
2 EX-10.1 amendment2tosahmoud-oncost.htm EX-10.1 21246
3 EX-10.2 context_menarini-supplyand.htm EX-10.2 311270
4 EX-31.1 cntx-20220630x10qexhibit311.htm EX-31.1 9117
5 EX-31.2 cntx-20220630x10qexhibit312.htm EX-31.2 9164
6 EX-32.1 cntx-20220630x10qexhibit321.htm EX-32.1 6305
12 image_0.jpg GRAPHIC 302
  Complete submission text file 0001842952-22-000071.txt   4975831

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20220630.xsd EX-101.SCH 35154
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20220630_cal.xml EX-101.CAL 33009
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20220630_def.xml EX-101.DEF 193107
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20220630_lab.xml EX-101.LAB 442899
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20220630_pre.xml EX-101.PRE 303447
52 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20220630_htm.xml XML 575892
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 221155608
SIC: 2834 Pharmaceutical Preparations